People

Alessio Ciulli

Alessio Ciulli chairs TRIMTECH’s scientific advisory board. His Dundee research focuses on targeted protein degradation, including VHL-binding ligands and PROTAC ternary-complex structures. He co-founded Amphista Therapeutics and leads Dundee’s Centre for Targeted Protein Degradation.